| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 09/04/2003 | US20030166077 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166076 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 09/04/2003 | US20030166075 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 09/04/2003 | US20030166074 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166071 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166051 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/04/2003 | US20030166004 Comprises synthetic or genetically engineered peptide or polypeptide which comprises endothelial cell binding peptides (ECBP) for inhibit angiogenesis and related diseases such as cancer, arthritis and vision defects |
| 09/04/2003 | US20030165996 Producing protein with altered immunogenicity or improved stability/in situ half-life; veterinary medicine; pharmacology |
| 09/04/2003 | US20030165969 Non-nucleotide containing enzymatic nucleic acid |
| 09/04/2003 | US20030165964 Using conductive polymers such as polyphenylene-vinylene to determine sequence of preferential polynucleotides |
| 09/04/2003 | US20030165963 Comprises microarray of immobilized oligonucleotides for transcription, amplification and hybridization analysis |
| 09/04/2003 | US20030165961 UV excitable energy transfer reagents |
| 09/04/2003 | US20030165935 Quantitating target nucleotide sequences using labeled probes; forensics; infection diagnosis; heredity testing; organ transplantation |
| 09/04/2003 | US20030165934 Methods and compositions in checkpoint signaling |
| 09/04/2003 | US20030165922 System, method and apparatus for transgenic and targeted mutagenesis screening |
| 09/04/2003 | US20030165920 Identifying polymerase chain reaction primer extension products using fluorescence energy transfer (FET); detecting allelic variation/restriction fragment length polymorphisms |
| 09/04/2003 | US20030165905 Polymer coated surfaces for microarray applications |
| 09/04/2003 | US20030165900 Ribozymes; antisense oligonucleotides; hammerhead/hairpin motifs |
| 09/04/2003 | US20030165895 Methods of detecting, diagnosing and treating cancer and identifying neoplastic progression |
| 09/04/2003 | US20030165888 Detecting point mutations/single nucleotide polymorphisms; genetic disorders |
| 09/04/2003 | US20030165880 For detecting single nucleotide polymorphisms (SNPs) in diploid organisms using modified nucleotides/residues |
| 09/04/2003 | US20030165859 For allele specific polymerase chain reactions; chemiluminescence |
| 09/04/2003 | US20030165849 Methods and reagents for introducing a sulfhydryl group into the 5'-terminus of RNA |
| 09/04/2003 | US20030165843 Microarray for profiling gene expression in cells and tissues; antisense agents; antitumor agents |
| 09/04/2003 | US20030165841 Use of phosphorothiolate polynucleotides in ligating nucleic acids |
| 09/04/2003 | US20030165840 Comprises replication of oligonucleotides for detection, diagnosis and treatment of cancer using 5-Fluorouracil-based chemotherapeutic regimen |
| 09/04/2003 | US20030165837 Method for screening DNA binding |
| 09/04/2003 | US20030165830 Arrays of nucleic acid probes for analyzing biotransformation genes |
| 09/04/2003 | US20030165823 Comprises oligonucleotide sequences immobilized in microfabricated patterns on matrix for analyzing cystic fibrosis transmembrane conductance regulator (CFTR) gene |
| 09/04/2003 | CA2477741A1 Nucleotide mimics and their prodrugs |
| 09/04/2003 | CA2477519A1 Method of error reduction in nucleic acid populations |
| 09/04/2003 | CA2477503A1 Surface modification, linker attachment, and polymerization methods |
| 09/04/2003 | CA2477408A1 An obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity |
| 09/04/2003 | CA2477225A1 Novel compositions and methods for cancer |
| 09/04/2003 | CA2476661A1 Method for generating amplified rna |
| 09/04/2003 | CA2475433A1 Trpm-2 antisense therapy using an oligonucleotide having 2'-o-(2-methoxyl)ethyl modifications |
| 09/04/2003 | CA2474751A1 Expression system for human brain-specific voltage-gated sodium channel, type 1 |
| 09/04/2003 | CA2472554A1 Methods of using fet labeled oligonucleotides that include a 3' 5' exonuclease resistant quencher domain and compositions for practicing the same |
| 09/03/2003 | EP1340766A1 Optically active DNA probe having phosphonic diester linkage |
| 09/03/2003 | EP1340765A2 Inverted chimeric and hybrid oligonucleotides |
| 09/03/2003 | EP1340764A2 Nucleic acid mediated electron transfer |
| 09/03/2003 | EP1340505A2 Therapeutic use of cis-element decoys in vivo |
| 09/03/2003 | EP1339870A2 Methods for external controls for nucleic acid amplification |
| 09/03/2003 | EP1339868A2 Methods for isolating centromere dna |
| 09/03/2003 | EP1339866A2 Human testis specific serine/threonine kinase |
| 09/03/2003 | EP1339798A2 Sulfonated diarylrhodamine dyes |
| 09/03/2003 | EP1339737A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 09/03/2003 | EP1339732A1 Specific double-stranded probes for homogeneous detection of nucleic acid and their application methods |
| 09/03/2003 | EP1086246A4 Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer |
| 09/03/2003 | EP1086178B1 An anthraquinone and its derivatives |
| 09/03/2003 | EP1023309B1 High surface density covalent immobilization of oligonucleotide monolayers |
| 09/03/2003 | EP0857210B1 Therapeutic antiangiogenic compositions and methods |
| 09/03/2003 | EP0763116B1 Recombinant viruses, preparation and use thereof in gene therapy |
| 09/03/2003 | EP0711349B1 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis |
| 09/03/2003 | CN1440424A Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof |
| 09/03/2003 | CN1439719A Human gene ZNF382 related to heart growth |
| 09/03/2003 | CN1439647A Saltant dihydrofolic acid reductase gene and application in mammal cell gene expression thereof |
| 09/03/2003 | CN1439646A Method for segregating nucleic acid |
| 09/03/2003 | CN1439645A Nucleotide with O-antigen idiocrasy against Ball's and shiga's-8 and colibacillus 0143 |
| 09/03/2003 | CN1120170C Antisense thiooligonucleotide of targeting C-raf cancer gene, medicinal composition containing same, and application in treating cancers |
| 09/02/2003 | US6613962 Given DNA sequence; insect resistance |
| 09/02/2003 | US6613894 Bonding the nucleoside to a solid support, deprotecting using an acid, reacting with a nucleoside phosphoramidite; oxidizing and coupling a biomolecule to the product |
| 09/02/2003 | US6613891 Polynucleotides that encode bovine inhibin |
| 09/02/2003 | US6613877 Polypeptide for use in the diagnosis and treatment of osteoporosis, paget's disease, electrolyte, kidney and heart defects |
| 09/02/2003 | US6613873 Covalently bound to a polyamide backbone; given formula; exhibit increased sequence specificity and binding affinity; resistant to enzyme degradation |
| 09/02/2003 | US6613751 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation |
| 09/02/2003 | US6613543 Fermentative carotenoid production |
| 09/02/2003 | US6613520 Methods for the survey and genetic analysis of populations |
| 09/02/2003 | US6613513 Sequencing by incorporation |
| 09/02/2003 | US6613508 Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques |
| 09/02/2003 | US6613331 Vaccine against Lyme disease |
| 09/02/2003 | US6613322 Administering enzyme inhibitors |
| 08/28/2003 | WO2003070974A2 Mismatch repair detection |
| 08/28/2003 | WO2003070970A2 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA) |
| 08/28/2003 | WO2003070968A2 RNA INTERFERENCE MEDIATED INHIBITION OF GASTRIC INHIBITORY POLYPEPTIDE (GIP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/28/2003 | WO2003070965A2 The eaat2 promoter and uses thereof |
| 08/28/2003 | WO2003070961A1 Chimeric cannulae proteins, nucleic acids encoding them and methods for making and using them |
| 08/28/2003 | WO2003070941A2 Method for the identification of tissue-specific regulatory sequences |
| 08/28/2003 | WO2003070920A1 Vaccination and vaccine and drug delivery by topical application of vectors and vector extracts recombinant vectors, and noninvasive genetic immunization, expression products therefrom,and uses thereof |
| 08/28/2003 | WO2003070918A2 Rna interference by modified short interfering nucleic acid |
| 08/28/2003 | WO2003070914A2 RNA INTERFERENCE MEDIATED INHIBITION OF FOS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/28/2003 | WO2003070912A2 RNA INTERFERENCE MEDIATED INHIBITION OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/28/2003 | WO2003070911A2 Rna interference mediated inhibition of type 1 insulin-like growth factor receptor (igf-1r) |
| 08/28/2003 | WO2003070910A2 INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND VEGF RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/28/2003 | WO2003070904A2 Human rnase iii and compositions and uses thereof |
| 08/28/2003 | WO2003070903A2 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/28/2003 | WO2003070895A2 RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/28/2003 | WO2003070889A2 Prostate specific genes and the use thereof in design or therapeutics |
| 08/28/2003 | WO2003070886A2 Inhibition of protein tyrosine phosphatase type iva expression byshort interfering nucleic acid |
| 08/28/2003 | WO2003070882A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and used thereof |
| 08/28/2003 | WO2003070768A2 Cd40 splice variants,method of detection thereof, compositions comprising said variant(s) or nucleic acid encoding the same and use thereof |
| 08/28/2003 | WO2003070750A2 Rna interference mediated inhibition of hepatitis c virus |
| 08/28/2003 | WO2003070744A1 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/28/2003 | WO2003070741A1 Phosphoramidites and use thereof in the preparation of oligonucleotides |
| 08/28/2003 | WO2003070221A1 Chemosensitizing with liposomes containing oligonucleotides |
| 08/28/2003 | WO2003070193A2 RNA INTERFERENCE MEDIATED INHIBITION OF HIV GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/28/2003 | WO2003070174A2 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
| 08/28/2003 | WO2003069980A2 Precise breeding |
| 08/28/2003 | WO2003062273A3 Modulator of the notch signalling pathway and use thereof in medical treatment |
| 08/28/2003 | WO2003059926A3 METHODS AND COMPOSITIONS FOR AMINOACYL-tRNA SYNTHESIS |